INSIGHTS & NEWS
Maximizing 2020
Retrospectively, it is clear that in every economic/market downturn, some companies took aggressive actions that enabled them to outperform competitors during the ensuing rebound. In January 2020, every healthcare CEO anticipated a good year ahead....
COVID-19: Business Impact
Following more than 200 meetings by FSI’s senior team at the JP Morgan Conference, we identified a shared perspective on the opportunities and challenges for the year ahead.
Q1 2020: Healthcare Executives Foresee Significant Change
Following more than 200 meetings by FSI’s senior team at the JP Morgan Conference, we identified a shared perspective on the opportunities and challenges for the year ahead.
Fletcher Spaght Inc. Celebrates 36th Anniversary
Fletcher Spaght Inc. proudly celebrates 36 years as a leader in growth-focused strategy consulting.
2019 Hospital C-Suite Medtech Purchasing Survey
Following more than 200 meetings by FSI’s senior team at the JP Morgan Conference, we identified a shared perspective on the opportunities and challenges for the year ahead.
Fletcher Spaght Managing Partner to Receive NACD Director of the Year Award
In recognition of his service as Chairman of Spectranetics and a Director of Axcelis, Fletcher Spaght, Inc. Managing Partner, R. John Fletcher, will receive the Director of the Year Award from The National Association of Corporate Directors (NACD), the authority on boardroom practices representing more than 19,000 corporate board members.
